MedTrace Logo

PICR-b Nasopharyngeal S. Pneumoniae and Nasal S. Aureus Carriage Study

NCT03064620 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 12800

Last updated 2017-02-27

No results posted yet for this study

Summary

Objective: PCV effects on S. pneumoniae and S. aureus carriage in a population based study. The major specific aims:

1. To compare different PCV vaccination policies, by cross-sectional repeated surveillance of closely related populations living in regions with different vaccination policies.
2. To compare the epidemiology, predictors and outcomes of antibiotic resistant S. aureus and S. pneumoniae in different regions of the PICR.

Study design: Annual / Biannual cross-sectional surveillance of nasal S. aureus carriage and nasopharyngeal S. pneumoniae carriage in children and one of their parents.

Conditions

  • Streptococcus Pneumoniae

Interventions

BIOLOGICAL

PCV

PCV7 was introduced in Israel (IL and EJ) in July 2009 PCV13 replaced PCV7 in IL and EJ on Oct 2010 PCV10 was introduced in PA in 2011

Sponsors & Collaborators

  • Palestinian-Israeli Collaborative Research (PICR)

    collaborator OTHER

  • United States Agency for International Development (USAID)

    collaborator FED

  • The Israeli National Institute for Health Policy Research

    collaborator UNKNOWN

  • Maccabi Healthcare Services, Israel

    collaborator OTHER

  • Sheba Medical Center

    lead OTHER_GOV

Principal Investigators

  • Dror Harats, Prof. · IRB Committee Sheba Medical Center Israel

Eligibility

Max Age
5 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2020-08-31
Completion
2022-01-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03064620 on ClinicalTrials.gov